What one share of Cel-Sci holds
CEL-SCI Corporation is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body’s natural defense system.
Cel-Sci’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$2.57 |
|---|---|
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$1.90 |
| Cash and investments | $0.37 |
| Debt | $0.45 |
| Book value | $0.62 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2009 | — | −$2,325 | — | — | — | — |
| 2011 | $34.40 | −$1,114 | $7.80 | −$819.19 | — | — |
| 2012 | $7.58 | −$582.45 | $1.63 | −$364.66 | — | — |
| 2013 | $3.95 | −$494.92 | $2.53 | −$338.12 | — | — |
| 2014 | $3.37 | −$366.28 | $1.33 | −$293.75 | — | — |
| 2015 | — | −$315.31 | $0.67 | −$217.28 | — | — |
| 2016 | — | −$70.97 | $0.19 | −$142.50 | — | — |
| 2017 | — | −$57.34 | $0.04 | −$52.40 | — | — |
| 2018 | — | −$56.19 | $0.00 | −$23.62 | — | — |
| 2019 | — | −$21.30 | — | — | — | $4.37 |
| 2020 | — | −$24.71 | $2.17 | −$14.63 | — | $15.28 |
| 2021 | — | −$27.06 | $6.65 | −$20.50 | — | $39.25 |
| 2022 | — | −$26.16 | $0.44 | −$13.13 | — | $22.21 |
| 2023 | — | −$21.83 | $0.24 | −$15.65 | — | $8.36 |
| 2024 | — | −$15.31 | $0.05 | −$10.49 | — | $6.05 |
| 2025 | — | −$6.27 | $0.01 | −$4.23 | — | $1.99 |
Common questions about Cel-Sci
How much does one share of Cel-Sci earn?
Over the last 12 months, Cel-Sci lost $2.57 for each share.
Does Cel-Sci pay a dividend?
Cel-Sci didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Cel-Sci’s book value per share?
Cel-Sci’s book value is $0.62 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Cel-Sci have?
Each share of Cel-Sci has $0.37 of cash and investments and $0.45 of debt, as of June 30, 2026.
What is Cel-Sci’s free cash flow per share?
−$1.90 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Cel-Sci bought back shares?
Cel-Sci’s share count rose about 22679% from 2009 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.